Blood test predicts Alzheimer’s disease progression years before brain scan changes
Posted:
Estimates suggest that more than 7 million American adults are living with Alzheimer’s disease. Receiving a timely diagnosis can provide many benefits, such as helping to reduce cognitive and functional decline and allowing an individual to prioritize their health.
We are pleased to welcome genedrive as a sponsor and exhibitor at this year’s GIANT Health Event.
Based in Manchester, genedrive is a diagnostics company developing rapid pharmacogenetic testing solutions designed to support safer, more effective prescribing decisions. By helping…
As healthcare systems continue to evolve, ensuring that new technologies deliver real value for patients, professionals, and the wider health and care system is more important than ever.
At GIANT Health, we are pleased to highlight our exhibitor Health Technology…